Xenon Pharmaceuticals (XENE) Q2 2023 Earnings

9AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.72
-0.65
-0.59
-0.52

Details

Expected EPS
-0.7
Actual EPS
-0.72
Surprise EPS
-0.02
Surprise Percent
+2.86%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -0.72 per share for Q2 2023.

0 Comments

Share your thoughts